tumor localization systems, tumor localization, elekta, radiation therapy

Elekta X-ray Volume Imaging (XVI)


September 13, 2013 – Integrated with Versa HD linear accelerator, Elekta has introduced new intra-fraction imaging capabilities within its X-ray Volume Imaging (XVI) system. During treatment, XVI now provides the tools to monitor and manage internal motion, supporting the clinician's efforts to increase therapeutic doses delivered to the tumor while reducing healthy tissue exposure.

"Regardless of patient immobilization, both the tumor and adjacent critical structures may move during treatment delivery. Historically, this has presented a significant challenge in delivering highly targeted treatments," says Dee Mathieson, Senior Vice President, Oncology Business Line Management.

"On a second by second basis, the precise location of the tumor and sensitive healthy structures can now be visualized, helping clinicians accurately deliver dose to the tumor while minimizing normal tissue exposure,” she adds

Elekta's XVI, which is also available on other Elekta radiotherapy delivery systems, includes 2-D, 3-D and 4-D intra-fraction imaging to support live imaging during sophisticated delivery techniques, such as Volumetric Modulated Arc Therapy (VMAT).

The new capabilities within XVI include seamless integration with Elekta's Mosaiq image-enabled oncology information system. XVI and Mosaiq work in harmony to deliver highly automated imaging workflow for improved control, efficiency, and performance. With image data available within the Oncology Information System, patient images, as well as setup and correction data, can be accessed as an integral part of the patient's electronic medical record.

The XVI 5.0 is pending FDA 510(k) clearance and not yet available for sale in the United States.


Related Content

News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Radiation Therapy

February 8, 2024 — RaySearch Laboratories AB announced that The Royal Marsden NHS Foundation Trust, a specialist cancer ...

Time February 08, 2024
arrow
News | Treatment Planning

February 2, 2024 — RaySearch Laboratories announced that the number of radiotherapy centers that have chosen RayStation ...

Time February 02, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
Feature | Artificial Intelligence

Coherent Market Insights has recently published a report, titled, Artificial Intelligence in Oncology Market, By ...

Time January 12, 2024
arrow
Subscribe Now